PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.180
https://www.valueinhealthjournal.com/article/S1098-3015(20)32436-0/fulltext
Title :
PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32436-0&doi=10.1016/j.jval.2020.08.180
First page :
Section Title :
Open access? :
No
Section Order :
10138